We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Brain Imaging Study Identifies Biological Differences Between PTSD and Traumatic Brain Injuries

By HospiMedica International staff writers
Posted on 19 May 2015
The results of a study intended to help identify the biological differences, and treatment options for Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI) have been published in the April 2015 special US Veterans Issue of the journal Brain Imaging and Behavior.

The research team which included brain-imaging scientists from Amen Clinics (USA), the University of California, Los Angeles (UCLA; Los Angeles, CA, USA), the Thomas Jefferson University (Philadelphia, PA, USA) and the University of British Columbia (UBC; Vancouver, BC, Canada), found that they could correctly differentiate 94% of PTSD and TBI cases from each other. More...


Improved diagnosis could lead to improved treatment for more than 400,000 US military personnel and veterans been diagnosed with PTSD or TBI since 2001. Treatments for PTSD differs from those for TBI, and for this reason it is important to be able distinguish between the two conditions.

Theodore Henderson, MD, PhD, member of the research team, said, "The need for a diagnostic tool to reliably distinguish PTSD from TBI in Veteran populations is urgent. Prior attempts to use imaging studies such as CT scans, MRIs, and conventional X-rays have been unsuccessful. This study uses Single Photon Emission Computed Tomography (SPECT) that looks directly at cerebral blood flow and indirectly at brain activity. SPECT brain imaging, a nuclear medicine technique, can show areas of over-activity and under-activity in the brain and can illustrate changes in brain function with treatment."

Related Links:

Amen Clinics 
UCLA
Thomas Jefferson University



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Surgical System
Stealth AXiS
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.